---
schema_version: "secwatch.filing_event.v1"
accession: "0001014739-24-000007"
form_type: "8-K"
ticker: "OPCH"
cik: "0001014739"
company_name: "Option Care Health, Inc."
filed_at: "2024-02-22T23:59:59+00:00"
generated_at: "2026-06-05T18:03:54.811025+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Option Care Health Q4 revenue up 9.5% to $1.12B; EPS $0.32; FY guides $4.6-4.8B

## Summary
- Q4 net revenue $1,124.4M (+9.5% YoY); net income $57.2M ($0.32 EPS) vs $47.5M ($0.26 EPS).
- Full-year 2023 revenue $4,302.3M (+9.1%); net income $267.1M ($1.48 diluted EPS) vs $150.6M ($0.83 EPS).
- FY 2024 guidance: revenue $4.6B-$4.8B; Adjusted EBITDA $425M-$450M; cash from ops ≥$300M.
- Board authorized $250M additional share repurchase after completing prior $250M authorization.
- Adjusted EBITDA Q4 $111.6M (+18.4% YoY); FY $425.2M (+24% YoY); cash flow from ops FY $371.3M (+38.8%).

## SEC filing metadata
- accession: 0001014739-24-000007
- form_type: 8-K
- ticker: OPCH
- cik: 0001014739
- company_name: Option Care Health, Inc.
- filed_at: 2024-02-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1014739/000101473924000007/0001014739-24-000007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1014739/000101473924000007/bios-20240222.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001014739-24-000007
- JSON: https://secwatch.observer/filing/0001014739-24-000007.json
- Plain text: https://secwatch.observer/filing/0001014739-24-000007.txt

## Key facts
- Earnings Releases
  Option Care Health, Inc. reported fourth quarter and full year ended December 31, 2023 results: revenue Net revenue of $1,124.4 million, net income Net income of $57.2 million, EPS $0.32 earnings per share.
  - Period: fourth quarter and full year ended December 31, 2023
  - Revenue: Net revenue of $1,124.4 million
  - Net income: Net income of $57.2 million
  - EPS: $0.32 earnings per share
  - Result: reported results
  source text: site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights • Net revenue of $1,124.4 million, up 9.5% compared to $1,027.2 million in the fourth quarter of 2022 • Gross profit of $247.1 million, or 22.0% of revenue, up 6.9% compared to $231.1 million, or 22.5% of
  evidence_url: https://www.sec.gov/Archives/edgar/data/1014739/000101473924000007/0001014739-24-000007-index.htm
- Earnings Releases
  Option Care Health, Inc. reported full year 2024 results: revenue Net revenue of $4.6 billion to $4.8 billion. Guidance reaffirmed.
  - Period: full year 2024
  - Revenue: Net revenue of $4.6 billion to $4.8 billion
  - Guidance: reaffirmed
  - Result: guidance update
  source text: For the full year 2024, Option Care Health expects to deliver the following financial results: • Net revenue of $4.6 billion to $4.8 billion • Adjusted EBITDA of $425 million to $450 million • Cash flow from operations of at least $300 million
  evidence_url: https://www.sec.gov/Archives/edgar/data/1014739/000101473924000007/0001014739-24-000007-index.htm
- Earnings Releases
  Option Care Health, Inc. reported full year ended December 31, 2023 results: revenue Net revenue of $4,302.3 million, net income Net income of $267.1 million, EPS $1.48 diluted earnings per share.
  - Period: full year ended December 31, 2023
  - Revenue: Net revenue of $4,302.3 million
  - Net income: Net income of $267.1 million
  - EPS: $1.48 diluted earnings per share
  - Result: reported results
  source text: Full Year 2023 Financial Highlights • Net revenue of $4,302.3 million, up 9.1% compared to $3,944.7 million in full year 2022 • Gross profit of $981.2 million, or 22.8% of revenue, up 13.2% compared to $866.9 million, or 22.0% of revenue, in full year 2022 • Net income of $267.1 million, or $1.48 diluted earnings per share, compared to net income of $150.6 million, or $0.83 earnings per share, in full year 2022
  evidence_url: https://www.sec.gov/Archives/edgar/data/1014739/000101473924000007/0001014739-24-000007-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.